L19il2

Other Medications

1 Clinical Trials

Description

L19IL2 is an investigational medication currently being studied in clinical trials for certain advanced solid tumors, including metastatic colorectal cancer. It is being evaluated in combination with another investigational drug, ruxolitinib. The goal of the trials is to determine the safety and effectiveness of this combination therapy. L19IL2 is being studied in patients whose colorectal cancer has specific characteristics, such as BRAF mutations, EGFR mutations, MSI status (MSS), and wild-type VEGF. It is important to note that L19IL2 is not yet approved for use in colorectal cancer or any other condition and is only available within the context of clinical trials.

Mechanism of Action

L19IL2 is an investigational medication. The specific way it works (its mechanism of action) is still being studied. It is designed to target specific processes involved in cancer growth and spread. Clinical trials are evaluating how L19IL2 affects tumor cells and the body's response to cancer.

Side Effects

As L19IL2 is an investigational drug in early-phase clinical trials (Phase 1) The full range of potential side effects is still being evaluated. Safety is a primary focus of these early trials. Participants in the trials are closely monitored for any adverse events. Specific side effects associated with L19IL2 will become clearer as more data is gathered from ongoing and future clinical studies.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT07566897 Phase 1
Not yet recruiting
A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors
Italy

Quick Info

CategoryOther Medications
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
772 trials
Leucovorin
Other Medications
632 trials
Trifluridine
Other Medications
46 trials
Paclitaxel
Other Medications
43 trials
Cyclophosphamid
Other Medications
40 trials
Cyclophosphamide
Other Medications
39 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.